Sou Hu Cai Jing·2025-08-06 10:37Core Viewpoint - Company BeiGene announced an upward revision of its revenue forecast for 2025, expecting revenue to be between RMB 35.8 billion and RMB 38.1 billion, an increase of RMB 600 million from the previous estimate [1] Revenue and Expenses - The company anticipates total R&D, sales, and management expenses to be between RMB 29.5 billion and RMB 31.9 billion, consistent with prior adjustments [1] - The gross margin is expected to be in the mid-to-high range of 80% to 90%, also revised upward from previous estimates [1] Cash Flow and Profitability - The company expects its annual revenue to exceed the total of its cost of goods sold, sales expenses, management expenses, and R&D expenses [1] - The net cash flow from operating activities, after deducting capital expenditures for fixed asset purchases, is projected to be positive [1]